Cite
HARVARD Citation
Koh, L. et al. (2023). Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study. Journal of medical virology. 95 (2), p. n/a. [Online].